What 'USP' after a drug name means

In an enforcement record dated Oct. 15, 2025, FDA logged a Class II recall of "Levothyroxine Sodium Tablets, USP, 88 mcg," a strength of the thyroid hormone levothyroxine. The reason given was that long-term stability testing had found the tablets' assay content "below the approved specification range." The letters USP were printed on the bottle the whole time.

That is common in the federal record. GxRadar analyzed the 18,076 drug recall records in FDA's enforcement database¹ from June 2012 through Oct. 28, 2026, and found 3,840, about 21 percent, describing a product with "USP" in its name or description. The share was 36 percent in 2025.

Still, the letters carry weight. They point to a binding public standard, written outside the government and enforced by FDA under a 1938 law. What they do not mean is that anyone tested the bottle on the shelf, a distinction that matters when reading a prescription label.

Where the letters come from

USP stands for the United States Pharmacopeia. According to the organization's own history², a group of physicians published the first edition in 1820 with formulas for 217 drugs considered the "most fully established and best understood" of the day. The USP timeline³ dates that first book to Dec. 21, 1820. A rival compendium, the National Formulary, followed in 1888, and in 1975 USP bought it and combined the two into one publication, the USP–NF.

Federal law adopted the books early. The 1906 Food and Drugs Act, USP says³, "mandates that drugs meet the standards of strength, quality, and purity" in the USP and NF. The Federal Food, Drug, and Cosmetic Act of 1938 kept that link and extended it to drug names and labeling.

At the core is the monograph, a written standard for one drug substance or product that sets tests and limits for identity, strength, quality and purity, along with packaging and labeling requirements. When "USP" follows a drug name, as in "Levothyroxine Sodium Tablets, USP," the maker is saying the product is the article described in that monograph and meets it.

What the law does with a monograph

Federal drug law names the USP and NF in its definitions and then uses them in three places.

An FDA official walked through the same provisions in a December 2025 presentation⁷, describing how USP and NF standards "can be used by FDA (via the FD&C Act) to support charges of" adulteration and misbranding.

Those standards bind whether or not the letters appear. On its official text FAQ⁸, USP says monographs apply to any article marketed in the United States as a drug or drug ingredient, and that "compliance with the monograph is required regardless of whether the article is designated as 'USP' or 'NF' on the label." Its example is ibuprofen tablets, where the monograph applies to every product labeled "Ibuprofen Tablets," prescription or over the counter. A generic bottle without the letters is held to the same standard as one with them.

Who writes the standards, and who enforces them

USP writes the monographs through volunteer expert committees and publishes proposals for public comment. It does not police them. On its legal recognition page⁹, USP says it "has no role in enforcement" of the provisions that recognize its standards, "which is the responsibility of FDA." USP does not approve drugs. The levothyroxine recall above, for instance, cited the product's "approved specification range," the limits set in the maker's FDA application.

FDA participates from the inside. USP's page on USP and FDA roles¹⁰ says more than 100 FDA staff serve as government liaisons on its committees and panels. FDA's 2025 presentation⁷ put the number of drug-center staff in that role at more than 130 during the 2020 to 2025 cycle, and described a review process in which FDA comments on proposed monographs before they become official. The same presentation listed a limit. FDA "is unable to disclose specific information necessary to revise monographs," because impurity data in drug applications is usually confidential, so updates depend on manufacturers sharing data. Outdated monographs, FDA said, "can be misleading to firms during product development."

The 2008 heparin contamination showed both sides of that arrangement. After the episode, FDA's 2013 guidance on crude heparin¹¹ told manufacturers to run tests to detect the contaminant "in addition to the USP monograph tests," and pointed to the current monograph's requirement to label the tissue and animal species a batch came from.

USP in the recall data

Because so many products carry the designation, it shows up across FDA's recall records. GxRadar counted, by year, how many records in the openFDA enforcement data¹ mention "USP" in the product description. The full year-by-year record is on our recalls page.

That rising share says more about which products get recalled and how they are named than about USP standards. A small set of records cite the compendium directly. GxRadar found 19 records whose stated reason began "Does Not Meet Monograph" or "Does Not Meet USP or OTC Monograph," eight citing "Failed USP Dissolution Test Requirements" and one citing failed USP content uniformity. The dissolution check is explained in our piece on dissolution testing. Most recalls of USP-labeled products cite other problems. By GxRadar's keyword search, about 1,270 of the 3,840 records mention manufacturing practice deviations and about 1,130 mention sterility, contamination or particulate matter; a record can fall in both groups.

Reading the letters

On a label, "USP" tells a reader that the product's name is recognized in the compendium and that its maker claims compliance. It does not say a third party tested the lot, and it does not rank one generic above another; GxRadar's guide to what generics share with brands covers the FDA requirements that sit on top. Readers who want to know whether a specific lot was pulled can follow GxRadar's steps on checking for recalls, and a pharmacist can answer questions about a particular product.

The standard itself keeps moving. USP publishes the USP–NF every year, and under its own rules text becomes binding only once it reaches its "official date," a status USP marks as "CURRENTLY OFFICIAL" in the online edition⁸.